Halozyme Therapeutics (HALO) Times Interest Earned: 2013-2025
Historic Times Interest Earned for Halozyme Therapeutics (HALO) over the last 13 years, with Sep 2025 value amounting to $50.73.
- Halozyme Therapeutics' Times Interest Earned rose 40.62% to $50.73 in Q3 2025 from the same period last year, while for Sep 2025 it was $41.53, marking a year-over-year increase of 63.47%. This contributed to the annual value of $30.48 for FY2024, which is 69.39% up from last year.
- As of Q3 2025, Halozyme Therapeutics' Times Interest Earned stood at $50.73, which was up 10.10% from $46.07 recorded in Q2 2025.
- Halozyme Therapeutics' 5-year Times Interest Earned high stood at $53.11 for Q2 2021, and its period low was $10.97 during Q2 2022.
- In the last 3 years, Halozyme Therapeutics' Times Interest Earned had a median value of $25.91 in 2024 and averaged $29.25.
- Per our database at Business Quant, Halozyme Therapeutics' Times Interest Earned skyrocketed by 4,384.26% in 2021 and then tumbled by 79.34% in 2022.
- Halozyme Therapeutics' Times Interest Earned (Quarterly) stood at $27.51 in 2021, then tumbled by 40.74% to $16.30 in 2022, then rose by 18.72% to $19.36 in 2023, then soared by 99.72% to $38.66 in 2024, then spiked by 40.62% to $50.73 in 2025.
- Its Times Interest Earned was $50.73 in Q3 2025, compared to $46.07 in Q2 2025 and $31.28 in Q1 2025.